|
Segment P&L (Unaudited) |
||||||||||||
| In 000 |
Materialise
Software |
Materialise
Medical |
Materialise
Manufact- uring |
Total
segments |
Unallocated
(1) |
Consoli-
dated |
||||||
| € | € | € | € | € | € | |||||||
| For the three months ended March 31, 2019 | ||||||||||||
| Revenues | 9,350 | 13,566 | 24,184 | 47,100 | 15 | 47,115 | ||||||
| Segment EBITDA | 2,961 | 1,773 | 3,695 | 8,429 | (2,423) | 6,006 | ||||||
| Segment EBITDA % | 31.7% | 13.1% | 15.3% | 17.9% | 12.7% | |||||||
| For the three months ended March 31, 2018 | ||||||||||||
| Revenues | 8,326 | 11,946 | 23,632 | 43,904 | (5) | 43,899 | ||||||
| Segment EBITDA | 2,324 | 2,060 | 3,133 | 7,517 | (2,381) | 5,136 | ||||||
| Segment EBITDA % | 27.9% | 17.2% | 13.3% | 17.1% | 11.7% | |||||||
Materialise Reports First Quarter 2019 Results
 |  | More MCAD News
|
|
(1) Non-cash stock-based compensation expenses represent the cost of
equity-settled and cash-settled share-based payments to employees.
RELATED NEWS
